FDA approves WATCHMAN FLX left atrial appendage closure (LAAC) device to reduce the risk of stroke.- Boston Scientific
Boston Scientific Corporation announced it has received FDA approval for the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.The next-generation WATCHMAN FLX device is indicated to reduce the… read more.